Production of nisin-loaded solid lipid nanoparticles for sustained antimicrobial activity

Food Control

Volumn 24, Issue 1-2, 2012, Pages 184-190

  Prombutara, Pinitphon ^a   Kulwatthanasal, Yokruethai ^a   Supaka, Nuttapun ^b   Sramala, Issara ^b   Chareonpornwattana, Supat ^a  

^a CHULALONGKORN UNIVERSITY   (Thailand)

^b NATIONAL SCIENCE AND TECHNOLOGY DEVELOPMENT AGENCY   (Thailand)

Author keywords

Antimicrobial activity; High pressure homogenization; Nisin; Solid lipid nanoparticles

Indexed keywords

LACTOBACILLUS PLANTARUM; LISTERIA MONOCYTOGENES;

EID: 80055066979     PISSN: 09567135     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.foodcont.2011.09.025     Document Type: Article

References (27)

1. Aasen I.M., Markussen S., Moretro T., Katla T., Axelsson L., Naterstad K. Interactions of bacteriocins sakacin P and nisin with food constituents. International Journal of Food Microbiology 2003, 87:35-43.
2. Almeida A.J., Runge S., Muller R.H. Peptide-loaded solid lipid nanoparticles (SLN): influence of production parameters. International Journal of Pharmaceutics 1997, 149:255-265.
3. Benech R.O., Kheadr E.E., Lacroix C., Fliss I. Antibacterial activities of nisin Z encapsulated in liposomes or produced in situ by mixed culture during cheddar cheese ripening. Applied and Environmental Microbiology 2002, 68:5607-5619.
4. Chi-Zhang Y., Yam L.K., Chikindas M.L. Effective control of Listeria monocytogenes by combination of nisin formulated and slowly released into a broth system. International Journal of Food Microbiology 2004, 90:15-22.
5. Colas J.C., Shi W., Rao V.S.N.M., Omri A., Mozafari M.R., Singh H. Microscopical investigations of nisin loaded nanoliposomes prepared by Mozafari method and their bacterial targeting. Micron 2007, 38:841-847.
6. De Vuyst L., Vandamme E.J. Nisin, a lantibiotic produced by Lactococcus lactis subsp. lactis: biosynthesis, fermentations and applications. Bacteriocins of lactic acid bacteria: Microbiology, genetics and applications 1994, 151-221. Blackie Academic and Professional, London, England. L. De Vuyst, E.J. Vandamme (Eds.).
7. Freitas C., Muller R. Effect of light and temperature on zeta potential and physical stability in solid lipid nanoparticle dispersions. International Journal of Pharmaceutics 1998, 168:221-229.
8. Gálvez A., Abriouel H., López R.L., Omar N.B. Bacteriocin-based strategies for food biopreservation. International Journal of Food Microbiology 2007, 120:51-70.
9. Heurtault B., Saulnier P., Pech B., Proust J.E., Benoit J.P. Physico-chemical stability of colloidal lipid particles. Biomaterials 2003, 24:4283-4300.
10. Hu F.Q., Hong Y., Yuan H. Preparation and characterization of solid lipid nanoparticles containing peptide. International Journal of Pharmaceutics 2004, 273:29-35.
11. Huang Y., Luo Y., Zhai Z., Zhang H., Yang C., Tian H., et al. Characterization and application of an anti-Listeria bacteriocin produced by Pediococcus pentosaceus 05-10 isolated from Sichuan Pickle, a traditionally fermented vegetable product from China. Food Control 2009, 20:1030-1035.
12. Jung D.S., Bodyfelt F.W., Daeschel M.A. Influence of fat and emulsifiers on the efficacy of nisin in inhibiting Listeria monocytogenes in fluid milk. Journal of Dairy Science 1992, 75:387-393.
13. Laridi R., Kheadr E.E., Benech R.O., Vuillemard J.C., Lacroix C., Fliss I. Liposome encapsulated nisin Z: optimization stability and release during milk fermentation. International Dairy Journal 2003, 13:325-336.
14. Liu W., Hansen N. Some chemical and physical properties of nisin, a small protein antibiotic produced by Lactococcus lactis. Applied and Environmental Microbiology 1990, 56:2551-2558.
15. Mehnert W., Mader K. Solid lipid nanoparticles: production, characterization and applications. Advanced Drug Delivery Reviews 2001, 47:165-196.
16. Muller H.R., Runge S.A., Ravelli V., Thunemann A.F., Mehnert W., Souto E.B. Cyclosporine-loaded solid lipid nanoparticles (SLN) drug-lipid physicochemical interaction and characterization of drug incorporation. European Journal of Pharmaceutics and Biopharmaceutics 2008, 68:535-544.
17. Olbrich C., Muller R.H. Enzymatic degradation of SLN-effect of surfactant and surfactant mixtures. International Journal of Pharmaceutics 1999, 180:31-39.
18. Rayman K., Malik N., Hurst A. Failure of nisin to inhibit outgrowth of Clostridium botulinum in a model cured meat system. Applied and Environmental Microbiology 1983, 46:1450-1452.
19. Reddy L.H., Vivek K., Bakshi N., Murthy R.S. Tamoxifen citrate loaded solid lipid nanoparticles (SLN): preparation, characterization, in vitro drug release, and pharmacokinetic evaluation. Pharmaceutical Development and Technology 2006, 11:167-177.
20. 2 anti-solvent precipitation for sustained antimicrobial activity. International Journal of Pharmaceutics 2004, 287:163-173.
21. da Silva Malheiros P., Daroit D.J., da Silveira N.P., Brandelli A. Effect of nanovesicle-encapsulated nisin on growth of Listeria monocytogenes in milk. Food Microbiology 2010, 27:175-178.
22. Soukharev R.A. Stability of lipid excipients in solid lipid nanoparticles. Advanced Drug Delivery Reviews 2007, 59:411-418.
23. Tjakko A., Lothar K., Colin H. Bacteriocin: modes of action and potentials in food preservation and control of food poisoning. International Journal of Food Microbiology 1995, 28:169-185.
24. WHO (World Health Organization) Specifications for identity and purity of some antibiotics. World Health Organization/Food Additives 1969, 69(34):53-67.
25. Wiedemann I., Breukink E., van Kraaij C., Kuipers O.P., Bierbaum G., de Kruijff B., et al. Specific binding of nisin to the peptidoglycan precursor lipid II combines pore formation and inhibition of cell wall biosynthesis for potent antibiotic activity. Journal of Biological Chemistry 2001, 276:1772-1779.
26. Wissing S.A., Kayser O., Muller R.H. Solid lipid nanoparticles for parenteral drug delivery. Advanced Drug Delivery Reviews 2004, 56:1257-1272.
27. Zimmermann E., Muller R.H. Electrolyte- and pH stabilities of aqueous solid lipid nanoparticle (SLN™) dispersions in artificial gastrointestinal media. European Journal of Pharmaceutics and Biopharmaceutics 2001, 52:203-210.